Archangels

1-15 of 34 Articles
Clock icon 2 minutes

Archangels invested more than £13.8 million during 2023 in eleven of Scotland’s best early-stage tech and life science companies. The total investment for 2023 among 11 businesses represents a small increase on Archangels’ investment activity in 2022 (£13.4m).

Clock icon 3 minutes

1nhaler, a Scotland-based drug delivery device developer, has raised £2 million to develop its unique single-use dry powder inhaler (DPI). The funding round was led by Archangels with support from Dr Yusuf Hamied, British Business Investments (BBI) and seed investors. Dr Hamied, non-executive

Clock icon 3 minutes

Glasgow-based integrated drug formulation and clinical trials specialist BDD has secured a fresh £2 million investment to fuel its expansion, responding to a surge in demand for its proprietary drug delivery technology and its niche clinical trial services. This funding initiative was led by p

Clock icon 3 minutes

Edinburgh-based life science firm Cytomos has successfully raised £4 million in a recent investment round for the development and market-testing of its Cytomos Dielectric Spectroscopy (CDS) technology. Archangels led this funding initiative with participation from notable investors such as Old

Clock icon 2 minutes

Scottish business angel syndicate Archangels has secured a £12 million co-investment agreement with British Business Investments through its Regional Angels Programme. The deal is set to empower the Edinburgh-based syndicate, which specialises in early-stage Scottish life sciences and technolo

Clock icon 2 minutes

Edinburgh-based enterprise training platform Administrate has secured a £5 million investment round from current backers Archangels, Mercia, and the Scottish National Investment Bank, with Hambro Perks joining the round as a fresh capital partner. The funding will fuel Administrate's rapid exp

Clock icon 3 minutes

Edinburgh-based healthtech company Hearing Diagnostics has completed a £1.1 million funding round and is now eyeing commercialisation in the domestic and US markets. Led by angel investment syndicate Archangels, the funding will unlock the spatial hearing screening technology’s market po

Clock icon 2 minutes

Neil Cunningham, founder of MatchPoint Hospitality Group, has been appointed to the board of Edinburgh-based investment syndicate, Archangels. Mr Cunningham set up MatchPoint in 1992, expanding its corporate hospitality offering from the UK to include clients as far afield as Hong Kong and Sydney, a

Clock icon 2 minutes

Edinburgh-based investment syndicate Archangels has generated up to £1.4 billion Gross Value Added (GVA) for the Scottish economy from its investments in the life sciences and tech sectors. The analysis, conducted by the University of Glasgow’s Adam Smith Business School, found that the

Clock icon 2 minutes

Burges Salmon has advised Cytomos Limited on its £1.6 million funding from a trio of investors to progress the development and qualification of its novel cell analysis platform, Cytomos Dielectric Spectroscopy (CDS).The fundraising was led by existing investor Archangels with participation fro

Clock icon 3 minutes

Edinburgh-based PhysioMedics has secured equity and grant funding totalling £1.5 million from Archangels, Scottish Enterprise and Innovate UK to allow it to accelerate its commercial growth and product roadmap, including expanding into European and Indian markets. The investment follows the ap

1-15 of 34 Articles